Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Targeted drug therapy is directed at proteins on vulvar cancer cells that help them grow, spread, or live longer. Targeted drugs work to destroy cancer cells or slow their growth. They have side effects different from chemotherapy and some are taken as pills.
Some targeted therapy drugs, for example, monoclonal antibodies, work in more than one way to control cancer cells and may also be considered immunotherapy because they boost the immune system. Different types of targeted drug therapy can be used to treat vulvar cancer.
An antibody-drug conjugate (ADC) is a monoclonal antibody linked to a chemotherapy drug. The antibody attaches to a target protein on cancer cells, so the chemo can be brought directly to the cancer cells.
This ADC connects the anti-HER2 antibody to the chemo drug deruxtecan. T-DXd can be used by itself to treat late-stage, HER2-positive vulvar cancer that has recurred after the first systemic treatment . This drug is given in a vein (IV) typically once every 3 weeks.
Common side effects include:
A less common, but serious side effect is decreased heart muscle strength, a condition called left ventricular dysfunction.
A very small number of vulvar cancers have changes in one of the NTRK genes, called NTRK gene fusions. Cells with these gene changes make abnormal TRK proteins, which can lead to abnormal cell growth and cancer.
Larotrectinib (Vitrakyi), entrectinib (Rozlytrek), or repotrectinib (Augtyro)
TRK inhibitors target and disable the proteins made by the NTRK genes. These drugs are taken as pills, once or twice daily.
Common side effects can include:
Less common but more serious side effects can include:
To learn more about how targeted drugs are used to treat cancer, see Targeted 슬롯 사이트 Therapy.
To learn about some of the side effects listed here and how to manage them, see Managing 슬롯 사이트-related Side Effects.
Developed by the 슬롯사이트 - 프라그마틱 무료 슬롯 게임 사이트 medical and editorial content team with medical review and contribution by the 무료슬롯 슬롯 게임 of Clinical Oncology (ASCO).
무료슬롯 College of Obstetricians and Gynecologists¡¯ Committee on Gynecologic Practice; 무료슬롯 슬롯 게임 for Colposcopy and Cervical Pathology (ASCCP). Committee Opinion No.675: Management of Vulvar Intraepithelial Neoplasia. Obstet Gynecol. 2016;128(4):e178-182.
Grimes C, Cunningham C, Lee M, Murina A. Use of topical imiquimod in the treatment of VIN: a case report and review of the literature. Int J Womens Dermatol. 2016;2(1):35-38.
Last Revised: May 2, 2025
슬롯사이트 - 프라그마틱 무료 슬롯 게임 사이트 medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the 슬롯사이트 - 프라그마틱 무료 슬롯 게임 사이트.